Rick Vreman is the winner or the award Best Master's Thesis 2016.
Rick developed an economic model that enables reliable predictions to be made of the medical and economic consequences of a decrease in the intake of additive sugars. If the sugar intake of the US population were to be reduced by 20%, the costs of healthcare would be reduced by more than USD 10 billion a year.
His thesis not only makes a substantial contribution to his field of study, pharmacy, but also to addressing a significant, contemporary societal problem.
Non-alcoholic fatty liver disease as a mediator of sugar effects; implications for the health and economic benefits of interventions in the US.